As part of our continuing search for potential anticancer drug candidates in YC-1 analogs, several 1-benzyl-3-(substituted aryl)-5-methylfuro[3,2-c]pyrazoles were synthesized and evaluated for their cytotoxicity against HL-60 cell line. Among these compounds, 1-benzyl-3-(5-hydroxymethyl-2-furyl)-5-methylfuro[3,2-c]pyrazole (1) showed more potency than YC-1. Through investigation of action mechanism, it was found that compound 1 induced terminal differentiation of HL-60 cells toward granulocyte lineage and promoted HL-60 cell differentiation by regulation of Bcl-2 and c-Myc proteins. Meanwhile, compound 1 also demonstrated apoptosis inducing effect. Such anti-leukemia mechanism of action is apparently different from that of YC-1 which mainly works by inducing apoptosis, but not cell differentiation. Therefore, compound 1 is identified here as a new lead compound of cell differentiating agent and apoptosis inducer for further development of new anti-leukemia agents.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmc.2006.12.001DOI Listing

Publication Analysis

Top Keywords

anti-leukemia agents
8
hl-60 cell
8
cell differentiation
8
synthesis furopyrazole
4
furopyrazole analogs
4
analogs 1-benzyl-3-5-hydroxymethyl-2-furylindazole
4
yc-1
4
1-benzyl-3-5-hydroxymethyl-2-furylindazole yc-1
4
yc-1 novel
4
novel anti-leukemia
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!